Skip to main navigation

Live - Top Menu

  • Clinical Trials
  • Investors & Media
  • Careers
  • Contact Us
Menu
Close

Main navigation

  • Our Focus
  • Our Research
  • Our Medicine
  • Our Story
Home > Investors & Media > Financial Information > SEC Filings
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

SEC Filings

SEC Filings

Filing date Form Description View
Mar 24, 2023 S-3ASR

S-3ASR

View HTML
0001104659-23-036680.pdf
0001104659-23-036680.rtf
0001104659-23-036680.xls
Mar 24, 2023 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
0001104659-23-036695.pdf
0001104659-23-036695.rtf
0001104659-23-036695.xls
Mar 24, 2023 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-23-036700.pdf
0001104659-23-036700.rtf
0001104659-23-036700.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 23, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-23-036043.pdf
0001104659-23-036043.rtf
0001104659-23-036043.xls
Mar 16, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-23-033307.pdf
0001104659-23-033307.rtf
0001104659-23-033307.xls
Mar 02, 2023 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-23-027633.pdf
0001104659-23-027633.rtf
0001104659-23-027633.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 02, 2023 10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML
0001558370-23-002693.pdf
0001558370-23-002693.rtf
0001558370-23-002693.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 27, 2023 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-23-025652.pdf
0001104659-23-025652.rtf
0001104659-23-025652.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 21, 2023 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-23-023549.pdf
0001104659-23-023549.rtf
0001104659-23-023549.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 16, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-23-022788.pdf
0001104659-23-022788.rtf
0001104659-23-022788.xls

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Live - Footer Menu

  • Privacy Policy
  • Privacy Shield Policy
  • Corporate Compliance
  • Terms of Use
  • Contact Us
  • Cookie Preferences
305 Madison Avenue|Morristown, NJ 07960|T: 844-782-ICPT
© 2023 Intercept Pharmaceuticals, Inc.